Synthesis in Drug Discovery and Development

22 March 2021 13:00 - 23 March 2021 17:00, United Kingdom


Introduction

A virtual symposium
Registration will close at 12.00 GMT on Thursday, 18th March

Synopsis

Synthesis is at the heart of drug discovery and development. The industry has increasingly demanded higher quality clinical candidates and has sought to exploit less druggable biological targets. Densely functionalised small molecules with a high degree of synthetic complexity are often the result of these demands. Successful programmes therefore require the application of innovative synthesis in all stages of discovery and development. The medicinal chemist’s toolbox is also enhanced by the introduction of novel biosostrere, often made available only through the application of new synthetic methods. This symposium aims to celebrate the crucial role of synthesis in the success of drug discovery and development.

Programme Theme and Features

The three main themes of the symposium will be:
• Innovative synthesis facilitating candidate discovery
• Novel bioisosteres and methodology applicable to drug discovery
• Overcoming challenges of scale-up and process scale chemistry

Who should attend

Chemists from industry and academia, including synthetic, medicinal and process chemists.

Call for Posters

Applications are invited for poster presentation. Posters will be displayed throughout both days and applicants are asked if they wish to provide a two-minute flash oral presentation when submitting their abstracts. The closing date for submission is 29th January. 

Registration 

Registration is open and fees include attendance at both afternoon sessions.
£50   RSC member
£75  Non-member
£25   RSC student* member
£37   Student* non-member
*Student means undergraduate or post-graduate, not post-doc.

Exhibition

We are offering two alternative packages to our valued supporters:  Exhibitor Sponsorship Package and Speaker Sponsorship Package.  Please refer to our website for details of these two packages. 

Sponsors

We are grateful to our sponsors for their support of this symposium, and additional sponsors are sought to support the low registration fees offered to students attendees.
Speakers
  • Catherine Alder GlaxoSmithKline, United Kingdom
  • Paul Brennan Structural Genomics Consortium, United Kingdom
  • Carine Guérot AstraZeneca, United Kingdom
  • Heather Hobbs GlaxoSmithKline, United Kingdom
  • Peter O'Brien University of York, United Kingdom
  • Simon Peace GlaxoSmithKline, United Kingdom
  • Paul Bulger Merck, United States
  • James Bull Imperial College London, United Kingdom
  • Thomas Fessard SpiroChem, Switzerland
  • Mike Shipman University of Warwick, United Kingdom

Sponsorship & supporting organisations
Venue

United Kingdom

Committee
Organised by
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*